233 related articles for article (PubMed ID: 33305042)
1. Overlapping variants in the blood, tissues and cell lines for patients with intracranial meningiomas are predominant in stem cell-related genes.
Hussein D; Dallol A; Quintas R; Schulten HJ; Alomari M; Baeesa S; Bangash M; Alghamdi F; Khan I; ElAssouli MM; Saka M; Carracedo A; Chaudhary A; Abuzenadah A
Heliyon; 2020 Nov; 6(11):e05632. PubMed ID: 33305042
[TBL] [Abstract][Full Text] [Related]
2. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines.
Khan I; Baeesa S; Bangash M; Schulten HJ; Alghamdi F; Qashqari H; Madkhali N; Carracedo A; Saka M; Jamal A; Al-Maghrabi J; AlQahtani M; Al-Karim S; Damanhouri G; Saini K; Chaudhary A; Abuzenadah A; Hussein D
Cancer Cell Int; 2017; 17():72. PubMed ID: 28736504
[TBL] [Abstract][Full Text] [Related]
4. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer.
Okawa Y; Iwasaki Y; Johnson TA; Ebata N; Inai C; Endo M; Maejima K; Sasagawa S; Fujita M; Matsuda K; Murakami Y; Nakamura T; Hirano S; Momozawa Y; Nakagawa H
J Hepatol; 2023 Feb; 78(2):333-342. PubMed ID: 36243179
[TBL] [Abstract][Full Text] [Related]
5. Next-Generation DNA Sequencing of Grade 1 Meningioma Tumours: A Case Report of Angiomatous and Psammomatous Meningiomas.
Taher MM; Ashour KM; Althaqafi BA; Mansouri A; Al-Harbi AA; Filfilan W; Bakhsh GY; Bantan NA; Saeed M; AlQuthami K
Cureus; 2024 Feb; 16(2):e54009. PubMed ID: 38476782
[TBL] [Abstract][Full Text] [Related]
6. Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors.
Kim E; Kim M; So K; Park YS; Woo CG; Hyun SH
Cancer Cell Int; 2020; 20():345. PubMed ID: 32742192
[TBL] [Abstract][Full Text] [Related]
7. Genomic profile of human meningioma cell lines.
Mei Y; Bi WL; Greenwald NF; Agar NY; Beroukhim R; Dunn GP; Dunn IF
PLoS One; 2017; 12(5):e0178322. PubMed ID: 28552950
[TBL] [Abstract][Full Text] [Related]
8. Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer.
Jo JH; Park SB; Chung J; Oh T; Lee HS; Chung MJ; Park JY; Bang S; Park SW; Jung DE; Song SY
BMC Cancer; 2024 Mar; 24(1):357. PubMed ID: 38509504
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants.
LaFramboise WA; Pai RK; Petrosko P; Belsky MA; Dhir A; Howard PG; Becich MJ; Holtzman MP; Ahrendt SA; Pingpank JF; Zeh HJ; Dhir R; Bartlett DL; Choudry HA
Mod Pathol; 2019 Jul; 32(8):1197-1209. PubMed ID: 30962504
[TBL] [Abstract][Full Text] [Related]
10. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.
Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
[TBL] [Abstract][Full Text] [Related]
11. Landscape of genetic variants in sporadic meningiomas captured with clinical genomics.
Leclair NK; Shen E; Wu Q; Wolansky L; Becker K; Li L; Bulsara KR
Acta Neurochir (Wien); 2022 Sep; 164(9):2491-2503. PubMed ID: 35881312
[TBL] [Abstract][Full Text] [Related]
12. K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
Yeung Y; Lau DK; Chionh F; Tran H; Tse JWT; Weickhardt AJ; Nikfarjam M; Scott AM; Tebbutt NC; Mariadason JM
Mol Oncol; 2017 Sep; 11(9):1130-1142. PubMed ID: 28544747
[TBL] [Abstract][Full Text] [Related]
13. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
14. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
15. Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers.
Khan AB; Patel R; McDonald MF; Goethe E; English C; Gadot R; Shetty A; Nouri SH; Harmanci AO; Harmanci AS; Klisch TJ; Patel AJ
J Neurooncol; 2023 Jun; 163(2):397-405. PubMed ID: 37318677
[TBL] [Abstract][Full Text] [Related]
16. Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
Schulten HJ; Hussein D
PLoS One; 2019; 14(5):e0215452. PubMed ID: 31083655
[TBL] [Abstract][Full Text] [Related]
17. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
18. Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing.
Das S; Idate R; Cronise KE; Gustafson DL; Duval DL
Mol Cancer Ther; 2019 Aug; 18(8):1460-1471. PubMed ID: 31175136
[TBL] [Abstract][Full Text] [Related]
19. Biallelic germline and somatic mutations in malignant mesothelioma: multiple mutations in transcription regulators including mSWI/SNF genes.
Yoshikawa Y; Sato A; Tsujimura T; Otsuki T; Fukuoka K; Hasegawa S; Nakano T; Hashimoto-Tamaoki T
Int J Cancer; 2015 Feb; 136(3):560-71. PubMed ID: 24916674
[TBL] [Abstract][Full Text] [Related]
20. Specific genetic aberrations of parathyroid in Chinese patients with tertiary hyperparathyroidism using whole-exome sequencing.
Li L; Sheng Q; Zeng H; Li W; Wang Q; Ma G; Xu X; Qiu M; Zhang W; Shan C
Front Endocrinol (Lausanne); 2023; 14():1221060. PubMed ID: 37854190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
